Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Protara Therapeutics - 11 Year Stock Price History | TARA

Historical daily share price chart and data for Protara Therapeutics since 2014 adjusted for splits and dividends. The latest closing stock price for Protara Therapeutics as of May 12, 2025 is 3.27.
  • The all-time high Protara Therapeutics stock closing price was 800.00 on July 17, 2015.
  • The Protara Therapeutics 52-week high stock price is 10.48, which is 220.5% above the current share price.
  • The Protara Therapeutics 52-week low stock price is 1.59, which is 51.4% below the current share price.
  • The average Protara Therapeutics stock price for the last 52 weeks is 3.22.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Protara Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.2444 5.5800 6.1400 3.2400 3.2700 -38.07%
2024 2.8542 2.1000 6.6700 1.6200 5.2800 181.58%
2023 2.5048 2.8000 3.9100 1.1250 1.8751 -30.03%
2022 3.8579 6.9000 6.9000 2.4300 2.6800 -60.30%
2021 11.0513 23.8600 23.8600 6.1500 6.7500 -72.12%
2020 26.1666 18.6310 60.7000 16.7600 24.2100 47.62%
2019 38.5828 98.4000 150.0000 9.9556 16.4000 -81.94%
2018 86.7428 76.0000 114.0000 61.2000 90.8000 19.47%
2017 66.9960 78.0000 106.0000 46.0000 76.0000 0.00%
2016 322.3937 561.6000 561.6000 74.0000 76.0000 -87.75%
2015 567.1563 424.0000 800.0000 415.2000 620.4000 49.13%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.124B $0.000B
Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company's portfolio includes, TARA-002, an investigational cell therapy being developed for the treatment of lymphatic malformations, and intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. Protara Therapeutics Inc., formerly known as ArTara Therapeutics, is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.416B 26.65
Daiichi Sankyo, - (DSNKY) Japan $45.628B 23.21
Takeda Pharmaceutical (TAK) Japan $43.656B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.760B 0.00
Merck (MKKGY) Germany $18.333B 15.17
Summit Therapeutics (SMMT) United States $18.277B 0.00
United Therapeutics (UTHR) United States $13.896B 12.29
Shionogi (SGIOY) Japan $12.760B 12.78
Neurocrine Biosciences (NBIX) United States $11.566B 39.62
IPSEN (IPSEY) France $9.541B 0.00
Orion OYJ (ORINY) Finland $8.215B 22.22
Corcept Therapeutics (CORT) United States $7.486B 60.85
Stevanato Group S.p.A (STVN) Italy $7.395B 45.22
Madrigal Pharmaceuticals (MDGL) United States $6.558B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.404B 0.00
Ionis Pharmaceuticals (IONS) United States $5.177B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.751B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.885B 10.11
Hypermarcas (HYPMY) Brazil $2.623B 17.26
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.325B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.105B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.665B 0.00
Guardian Pharmacy Services (GRDN) United States $1.560B 0.00
Indivior (INDV) United States $1.543B 6.54
Evotec AG (EVO) Germany $1.491B 0.00
Dyne Therapeutics (DYN) United States $1.375B 0.00
ARS Pharmaceuticals (SPRY) United States $1.311B 166.88
Ocular Therapeutix (OCUL) United States $1.115B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.057B 21.14
Enliven Therapeutics (ELVN) United States $0.983B 0.00
Harrow (HROW) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.16
Avadel Pharmaceuticals (AVDL) Ireland $0.873B 0.00
Ardelyx (ARDX) United States $0.811B 0.00
Cronos Group (CRON) Canada $0.786B 0.00
Xeris Biopharma Holdings (XERS) United States $0.766B 0.00
AleAnna (ANNA) United States $0.655B 0.00
Akebia Therapeutics (AKBA) United States $0.651B 0.00
KalVista Pharmaceuticals (KALV) United States $0.579B 0.00
Xencor (XNCR) United States $0.577B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.04
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Bioventus (BVS) United States $0.536B 13.62
Savara (SVRA) United States $0.513B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Relay Therapeutics (RLAY) United States $0.485B 0.00
Elite Pharmaceuticals (ELTP) United States $0.458B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.446B 0.00
Altimmune (ALT) United States $0.444B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Siga Technologies (SIGA) United States $0.424B 8.87
Amylyx Pharmaceuticals (AMLX) United States $0.400B 0.00
Organogenesis (ORGO) United States $0.400B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.371B 0.00
Oruka Therapeutics (ORKA) United States $0.360B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.84
Heron Therapeutics (HRTX) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.29
ProKidney (PROK) United States $0.254B 0.00
Aquestive Therapeutics (AQST) United States $0.227B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Avita Medical (RCEL) United States $0.185B 0.00
Nanobiotix S.A (NBTX) France $0.177B 0.00
OmniAb (OABI) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.171B 0.00
Inhibikase Therapeutics (IKT) United States $0.166B 0.00
Esperion Therapeutics (ESPR) United States $0.155B 0.00
4D Molecular Therapeutics (FDMT) United States $0.151B 0.00
Wellgistics Health (WGRX) United States $0.151B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Journey Medical (DERM) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.132B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Aldeyra Therapeutics (ALDX) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.111B 0.00
OptiNose (OPTN) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Cassava Sciences (SAVA) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.19
Dominari Holdings (DOMH) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 61.78
Telomir Pharmaceuticals (TELO) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
Avalo Therapeutics (AVTX) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Surrozen (SRZN) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Lipocine (LPCN) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.99
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00